Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

ClinicalTrials.gov ID: NCT00004127

Public ClinicalTrials.gov record NCT00004127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 20, 2026, 7:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Oxaliplatin in Combination With Fluorouracil and Leucovorin in Carcinoma of the Esophagus and Gastric Cardia

Study identification

NCT ID
NCT00004127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Chicago
Other
Enrollment
35 participants

Conditions and interventions

Interventions

  • FOLFOX regimen Drug
  • fluorouracil Drug
  • leucovorin calcium Drug
  • oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2000
Primary completion
Sep 30, 2002
Completion
Jul 31, 2003
Last update posted
Feb 10, 2013

2000 – 2003

United States locations

U.S. sites
21
U.S. states
8
U.S. cities
19
Facility City State ZIP Site status
Yale Comprehensive Cancer Center New Haven Connecticut 06520-8028
University of Illinois at Chicago Chicago Illinois 60612
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Louis A. Weiss Memorial Hospital Chicago Illinois 60640
Cancer Care Specialists of Central Illinois, S.C. Decatur Illinois 62526
Evanston Northwestern Health Care Evanston Illinois 60201
Ingalls Memorial Hospital Harvey Illinois 60426
Columbia LaGrange Memorial Hospital LaGrange Illinois 60525
Loyola University Medical Center Maywood Illinois 60153
Lutheran General Cancer Care Center Park Ridge Illinois 60068
Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois 61602
Central Illinois Hematology Oncology Center Springfield Illinois 62701
Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne Indiana 46885-5099
Michiana Hematology/Oncology P.C. South Bend Indiana 46617
Central Baptist Hospital Lexington Kentucky 40503
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0752
Lakeland Medical Center - St. Joseph Saint Joseph Michigan 49085
Roswell Park Cancer Institute Buffalo New York 14263-0001
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Grant/Riverside Methodist Hospitals Columbus Ohio 43214
Cancer Centers of the Carolinas Greenville South Carolina 29605

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00004127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2013 · Synced Jul 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00004127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →